RRMM
Showing 1 - 4 of 4
RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)
Not yet recruiting
- RRMM
- Other Plasma Cell Diseases
- (no location specified)
Dec 1, 2022
RRMM Trial in Worldwide (Melphalan-flufenamide, Dexamethasone)
Terminated
- RRMM
-
Glendale, California
- +9 more
Jul 18, 2022
Renal Impairment, RRMM Trial in Czechia, Greece, Poland (Melphalan flufenamide (melflufen), Dexamethasone)
Terminated
- Renal Impairment
- RRMM
- Melphalan flufenamide (melflufen)
- Dexamethasone
-
Brno, Czechia
- +9 more
Feb 2, 2022
RRMM Trial in Lishui, Wenzhou (CAR-T therapy in Relapsed/Refractory multiple myeloma)
Unknown status
- RRMM
- CAR-T therapy in Relapsed/Refractory multiple myeloma
-
Lishui, Zhejiang, China
- +2 more
Nov 16, 2020